Drug Information

Drug General Information
Drug ID
D0V7YQ
Former ID
DNC012914
Drug Name
4-((1H-imidazol-4-yl)methyl)-1-heptylpiperidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527818]
Structure
Download
2D MOL

3D MOL
Formula
C16H29N3
Canonical SMILES
CCCCCCCN1CCC(CC1)CC2=CN=CN2
InChI
1S/C16H29N3/c1-2-3-4-5-6-9-19-10-7-15(8-11-19)12-16-13-17-14-18-16/h13-15H,2-12H2,1H3,(H,17,18)
InChIKey
PKTDABXMBJERIM-UHFFFAOYSA-N
PubChem Compound ID
44406484
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [527818]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 527818Bioorg Med Chem Lett. 2006 Jan 15;16(2):395-9. Epub 2005 Oct 21.Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Ref 527818Bioorg Med Chem Lett. 2006 Jan 15;16(2):395-9. Epub 2005 Oct 21.Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.